MACM
March Altus Capital Management Portfolio holdings
AUM
$16M
This Quarter Return
+22.62%
1 Year Return
+18.92%
3 Year Return
+153.93%
5 Year Return
–
10 Year Return
–
AUM
$330M
AUM Growth
–
Cap. Flow
+$330M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
51.11%
Holding
28
New
28
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
DexCom
DXCM
|
$29.6M |
| 2 |
MON
Monsanto Co
MON
|
$23.2M |
| 3 |
Alkermes
ALKS
|
$18.8M |
| 4 |
HCA Healthcare
HCA
|
$17.5M |
| 5 |
West Pharmaceutical
WST
|
$16.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 75.36% |
| 2 | Financials | 8.92% |
| 3 | Materials | 7.02% |
| 4 | Industrials | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Thermo Fisher Scientific
TMO
$183B
| $5.74M | 1.74% |
+51,545
| New | +$5.74M |
|
|
ENZY
27
DELISTED
Enzymotec Ltd
ENZY
| $5.48M | 1.66% |
+202,962
| New | +$5.48M |
|
|
GNMK
28
DELISTED
GenMark Diagnostics, Inc
GNMK
| $2.98M | 0.9% |
+223,818
| New | +$2.98M |
|